Journal of Innovative Clinical Trials and Case Reports

Aims of the Journal

The Journal of Innovative Clinical Trials and Case Reports (JICTCR) aims to publish original, innovative, and clinically significant research that advances medical science, therapeutic development, and evidence-based healthcare practices. The journal seeks to provide an international platform for clinicians, physicians, researchers, healthcare professionals, and academicians to exchange valuable scientific knowledge and clinical experiences related to clinical trials, case studies, and translational medicine. JICTCR encourages research that enhances disease diagnosis, patient management, treatment strategies, and healthcare outcomes across diverse medical disciplines. The journal supports high-quality studies in clinical therapeutics, pharmacology, surgery, internal medicine, diagnostic technologies, and patient-centered care. It also promotes interdisciplinary research related to personalized medicine, artificial intelligence in healthcare, digital clinical systems, and emerging medical innovations. Through rigorous peer review and ethical publishing standards, the journal aims to encourage scientific excellence, transparency, and global collaboration in clinical research. JICTCR aspires to contribute to the advancement of modern medicine by supporting innovative clinical discoveries and evidence-driven healthcare solutions that improve patient well-being worldwide.

Scope of the Journal

The journal welcomes original research articles, review articles, short communications, and case reports covering but not limited to the following topics:

• Clinical Trial Design
• Phase I-IV Trials
• Case Reports
• Evidence-Based Medicine
• Research Methodology
• Statistical Analysis
• Regulatory Affairs
• Patient Safety

Article Types Accepted

• Original Research Articles
• Review Articles
• Systematic Reviews & Meta-Analyses
• Case Reports & Case Series
• Short Communications
• Letters to the Editor
• Editorials

Open Access Policy

This journal is fully open access. All articles are freely available online immediately upon publication. Authors retain copyright of their work under a Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.